Biggest News Aggregation in the World
๐Ÿ“ฐ Solid Tumor News

Page 5 - Solid Tumor News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Solid Tumor. Real-time updates on events, politics, business and more.

Cellectis Presents Clinical Data on AMELI-01 and Preclinical Data on Multiplex Engineering for Superior Generation of CAR T-cells at ASGCT 2023

NEW YORK, May 17, 2023 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today presents clinical data... | May 17, 2023
North Carolina United States France General New York Beatriz Aranda Orgilles Mark Frattini

Cellectis Presents Clinical Data on AMELI-01 and Preclinical Data on Multiplex Engineering for Superior Generation of CAR T-cells at ASGCT 2023

NEW YORK, May 17, 2023 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today presents clinical data... | June 12, 2023
New York United States North Carolina France General Daniel Lee Beatriz Aranda Orgilles

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Cellectis Announces Oral Presentation on AMELI-01 and Poster Presentation on Multiplex Engineering for Superior Generation of CAR T-cells at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

02.05.2023 - NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) - Cellectis (the โ€œCompanyโ€) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today ... Seite 1
Phasei Trial Adult Patients Acute Myeloid Production Advances Targeting Hematologic Solid Tumor

Cellectis Announces Oral Presentation on AMELI-01 and Poster Presentation on Multiplex Engineering for Superior Generation of CAR T-cells at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

NEW YORK, May 02, 2023 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will... | May 2, 2023
France General North Carolina United States New York Ashleyr Robinson Pascalyne Wilson

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science